欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 科研級生物類似抗體
  4. C1S (Sutimlimab Biosimilar) Recombinant Monoclonal Antibody

C1S (Sutimlimab Biosimilar) Recombinant Monoclonal Antibody

  • 貨號：
    CSB-RA003657MB3HU
  • 規(guī)格：
    ￥83486
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    C1S (Sutimlimab Biosimilar Antibody)重組單克隆抗體是一種用于科研領域的生物制劑，其研發(fā)旨在為補體系統(tǒng)相關機制的研究提供工具。該抗體以重組DNA技術制備，靶向補體系統(tǒng)中的關鍵組分C1s蛋白酶，通過特異性結(jié)合抑制其活性，從而調(diào)控補體經(jīng)典途徑的激活過程。 在科研應用中，該抗體可用于探究補體系統(tǒng)在自身免疫性疾病、炎癥反應及免疫調(diào)節(jié)中的作用機制。通過精準阻斷C1s介導的補體級聯(lián)反應，研究人員能夠在細胞模型或動物模型中分析補體過度激活與疾病發(fā)生的關聯(lián)，為闡明相關疾病的病理生理過程提供實驗支持。 該抗體具有高特異性和親和力，能夠與C1s蛋白形成穩(wěn)定復合物，有效抑制其對C4和C2的切割活性，進而阻止補體系統(tǒng)下游的C3轉(zhuǎn)化酶形成及后續(xù)的炎癥介質(zhì)釋放。其重組表達體系確保了批次間的一致性和高純度，適合在分子生物學、細胞生物學及動物實驗中作為特異性干預工具使用。 作為科研用試劑，該抗體為補體系統(tǒng)功能研究、潛在治療靶點驗證及相關藥物開發(fā)提供了重要實驗材料，助力深入探索補體調(diào)控在疾病治療中的應用前景。研究人員可通過結(jié)合該抗體的特異性抑制效應，開展機制驗證、信號通路分析及藥效評估某些實驗，推動補體相關領域的基礎研究與轉(zhuǎn)化醫(yī)學進展。
  • Uniprot No.：
  • 基因名：
  • 別名：
    C1s VH4V2 research-grade biosimilar; BIVV009 research-grade biosimilar; BIVV-009 research-grade biosimilar; Enjaymo research-grade biosimilar; Sutimlimab research-grade biosimilar; Sutimlimab (genetical recombination) (JAN) research-grade biosimilar; Sutimlimab (USAN/INN) research-grade biosimilar; sutimlimab-jome research-grade biosimilar; TNT009 research-grade biosimilar; TNT-009 research-grade biosimilar ;C1S antibody; Complement C1s subcomponent antibody; EC 3.4.21.42 antibody; C1 esterase antibody; Complement component 1 subcomponent s [Cleaved into: Complement C1s subcomponent heavy chain antibody; Complement C1s subcomponent chain A antibody; Complement C1s subcomponent light chain antibody; Complement C1s subcomponent chain B] antibody
  • 反應種屬：
    Human
  • 免疫原：
    Recombinant Human C1S protein
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標記方式：
    Non-conjugated
  • 克隆類型：
    Monoclonal
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    0.01M PBS，pH7.4
  • 產(chǎn)品提供形式：
    Liquid
  • 應用說明：
    Validation Status
    Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
    Guaranteed Quality
    ① Antibody purity?> 95% tested by SDS-PAGE.
    ② Endotoxin level < 0.1EU/ug tested by LAL method.
  • 儲存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    3-4 weeks
  • 用途：
    It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

產(chǎn)品評價

靶點詳情

  • 功能：
    C1s B chain is a serine protease that combines with C1q and C1r to form C1, the first component of the classical pathway of the complement system. C1r activates C1s so that it can, in turn, activate C2 and C4.
  • 基因功能參考文獻：
    1. TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins. PMID: 24695853
    2. Data indicate that complement C1s mRNA level was low in ICR-derived glomerulonephritis (ICGN) mice liver as compared with age-matched ICR mice. PMID: 23989031
    3. A molecular switch governs the interaction between the human complement protease C1s and its substrate, complement C4. PMID: 23592783
    4. Four positively charged amino acids on the serine protease domain appear to form a catalytic exosite that is required for efficient cleavage of C4 in the classical pathway of complement. PMID: 22855709
    5. Detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites. PMID: 20008834
    6. Interaction with the prime side residues at the cleavage point in C1s enhances the affinity of the enzyme for complement 2 and complement 4 substrates; these prime subsite residues mediate positive cooperativity in the cleavage of the substrate. PMID: 14674770
    7. full specificity of the enzyme using a randomized phage display library PMID: 16169853
    8. There are splice variants of C1s mRNA transcripts in normal human cells PMID: 18062908

    顯示更多

    收起更多

  • 相關疾?。?/div>
    Complement component C1s deficiency (C1SD); Ehlers-Danlos syndrome, periodontal type, 2 (EDSPD2)
  • 蛋白家族：
    Peptidase S1 family
  • 數(shù)據(jù)庫鏈接：

    HGNC: 1247

    OMIM: 120580

    KEGG: hsa:716

    STRING: 9606.ENSP00000328173

    UniGene: Hs.458355



×
生命科學計算平臺